CorTec develops fully implantable neurotechnology platforms designed for bidirectional neural recording and stimulation. The company’s systems are engineered to both sense brain activity and deliver targeted electrical stimulation within a single implantable device. Its platform supports chronic implantation and is intended to enable long-term interaction with neural circuits. CorTec positions its technology within regulated clinical and research environments rather than consumer applications.

The technology integrates neural sensing, signal processing, and stimulation into a closed-loop architecture. By continuously recording brain activity, the system can adapt stimulation parameters in response to detected neural patterns. This bidirectional design is intended to support more precise and responsive neuromodulation compared to open-loop systems. The implant emphasizes reliability, flexibility, and programmability for use across different therapeutic applications.

CorTec targets applications focused on restoring or modulating neural function in neurological disorders. The platform is intended for use within clinical research and therapeutic development pathways, supporting both investigational and translational use cases. Its focus on closed-loop neuromodulation reflects broader efforts to move toward adaptive, personalized neural therapies based on real-time brain signals.